Antibody

3개 · ADC 890 · Antibody 4071 · CGT 2714 · 다음 갱신 D-5 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved3 programs
AntibodyLimited DatastaleRochePhase 3

Active bevacizumab and Active dexamethasone (Active bevacizumab and Active dexamethasone)

Non-Ischemic Central Retinal Vein Occlusion · Non-Ischemic Central Retinal Vein Occlus

#Non-IschemicCentralRetinalVeinOc#Antibody#Phase3#monoclonal-antibody#Roche
Trials 1Status Active
AntibodyLimited DatastaleXiangya Hospital of Central Sou…Phase 1

Cardunilizumab (Cardunilizumab)

Sarcoma, Soft Tissue · Sarcoma, Soft Tissue

#SarcomaSoftTissue#Antibody#Phase1#monoclonal-antibody#Sarcoma+2
Trials 1Status Active
AntibodyLimited DatastaleRochePhase 3

Experimental Treatment: one course Rituximab/HD-Methotrexate, two courses of MATRix (Experimental Treatment: one course Rituximab/HD-Methotrexate, two courses of MATRix)

Primary Central Nervous System Lymphoma · Primary Central Nervous System Lymphoma

#PrimaryCentralNervousSystemLymph#Antibody#Phase3#monoclonal-antibody#Roche
Trials 1Status Recruiting